Scolazil en es it fr

Scolazil Brand names, Scolazil Analogs

Scolazil Brand Names Mixture

  • No information avaliable

Scolazil Chemical_Formula


Scolazil RX_link

No information avaliable

Scolazil fda sheet

Scolazil msds (material safety sheet)

Scolazil Synthesis Reference

No information avaliable

Scolazil Molecular Weight

309.469 g/mol

Scolazil Melting Point

< 25 oC

Scolazil H2O Solubility

Soluble as HCl salt

Scolazil State


Scolazil LogP


Scolazil Dosage Forms

Tablets (oral, 1 mg)

Scolazil Indication

Used for the symptomatic treatment of parkinsonism.

Scolazil Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Scolazil Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Scolazil side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Scolazil Patient Information

Scolazil Organisms Affected

Humans and other mammals